XELJANZ cpr pell 10 mg 56 pce
7680626300048
CH-62630
L04AA29
07.15.0.
Reimbursement limitations:
XELJANZ.01
Polyarthrite rhumatoïde (seulement dosage à 5 mg):
Seuls des spécialistes en rhumatologie ou des hôpitaux …
1 / 3
google
Details
- Product number
- 6263002
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- tofacitinibum 10 mg ut tofacitinibi citras, color.: E 132, E 133, excipiens pro compresso obducto.
Articles (1)
Xeljanz 10 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FIMDK |
Reimbursement information
Public price
CHF 1471.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2019
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 62630
- Drug name
- Xeljanz, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L04AA29
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/07/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XELJANZ cpr pell 10 mg 56 pce
- Description (DE)
- XELJANZ Filmtabl 10 mg 56 Stk
- Market launch
- 12/07/2013
- Narcotic (BTM)
- No